| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.86B | 39.32B | 41.32B | 33.82B | 12.19B | 10.67B |
| Gross Profit | 16.67B | 16.35B | 16.80B | 13.38B | 7.57B | 6.81B |
| EBITDA | 19.55B | 11.61B | 22.37B | 14.17B | 7.15B | 6.69B |
| Net Income | 485.00M | -11.31B | -3.13B | -7.37B | 1.01B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 100.52B | 104.56B | 122.76B | 134.00B | 34.43B | 34.09B |
| Cash, Cash Equivalents and Short-Term Investments | 4.33B | 5.31B | 3.78B | 3.73B | 3.90B | 2.09B |
| Total Debt | 33.75B | 39.51B | 43.67B | 49.00B | 14.76B | 15.40B |
| Total Liabilities | 63.21B | 69.62B | 76.28B | 85.33B | 21.03B | 21.70B |
| Stockholders Equity | 36.02B | 34.04B | 45.23B | 47.09B | 11.60B | 10.46B |
Cash Flow | ||||||
| Free Cash Flow | 4.13B | 4.43B | 6.16B | 3.32B | 2.42B | 2.34B |
| Operating Cash Flow | 5.23B | 5.38B | 7.48B | 4.30B | 2.80B | 2.74B |
| Investing Cash Flow | -755.00M | -349.00M | -1.26B | 3.52B | -56.00M | -703.00M |
| Financing Cash Flow | -3.72B | -3.75B | -5.84B | -7.74B | -853.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $30.41B | 16.20 | 17.33% | 0.75% | 14.91% | 9.30% | |
76 Outperform | $30.41B | 14.72 | 17.33% | 0.85% | 14.91% | 9.30% | |
75 Outperform | $198.52B | 16.24 | 11.78% | 1.10% | 3.61% | 152.34% | |
71 Outperform | $402.12B | 36.76 | 42.86% | ― | 15.49% | 35.54% | |
68 Neutral | $70.83B | 152.35 | 1.36% | ― | -4.29% | ― | |
67 Neutral | $15.50B | 32.69 | 5.59% | 0.76% | -16.36% | 29.53% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |